PACE (Personalized Adaptive Cortical Electro-Stimulation)

About Turing Medical

Turing Medical is a private, pre-revenue biotech firm founded in 2018, focusing on revolutionizing neuromodulation through AI and precision functional mapping. Its lead program is the PACE system, a non-invasive cortical stimulation therapy intended for severe depression and chronic pain, which is likely in pre-clinical or early clinical development. The company leverages its founders' seminal neuroscience research, published in journals like Nature, to build automated pipelines for brain targeting and also commercializes motion-reduction software (FIRMM) for improving MRI quality. Leadership includes a new CEO with medtech commercialization experience and a scientifically distinguished founding team.

Therapeutic Areas